Search results for: Healthcare Systems
Filter search results
Alan Maynard – Alas No More
5 February 2018
…idolatry, NHS disorganisation and redisorganisation, fallacious international comparisons of healthcare systems, general practice fund-holding, and sensible regulation of pharmaceuticals. Nearly all of his writing across this wide portfolio of topics…
OHE Lunchtime Seminar: How Can We Evaluate the Cost-effectiveness of Health System Strengthening? A Platforms Perspective
17 May 2018
…we evaluate the cost-effectiveness of health system strengthening? A platforms perspective’. To be held on 18th June 2018 from 12 p.m. to 2 p.m. Many investments in health systems…
Can a Strong Economic Case Be Made for Investing in the NHS?
1 January 2019
…ministries and some sections of the media – that health systems such as… Debate about funding has highlighted the difficulty of persuading sceptics that the NHS is a good use…
The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response
1 January 2011
This report examines and makes suggestions for the appropriate use of health technology assessment (HTA) in emerging markets. In particulary, it considers how the stage of development of the health…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
31 March 2015
…the routine collection of healthcare data is expanding, which is enhancing opportunities for research into the use and impact of healthcare services and interventions. Whilst important advances in data systems…
OHE is Pleased to Announce the Appointment Two New Economists: Marina Rodes Sanchez and Chris Sampson
12 October 2017
…Economics at City, University of London. Marina’s research interests include the evaluation of healthcare programs, including quality of life factors that directly impact decision making. She is also interested in…
Incentives, Competition, and Pharmaceutical Innovation in Europe: The Case of Direct Acting Antivirals for Hepatitis C
26 July 2018
…medicines are not used by some patients, countries, or systems. Quantities sold are lower than the quantity that would maximise social welfare, given the existence of the product. Our…
Reconciling MCDA and Augmented Cost-Effectiveness Analysis: Do We Get the Same Decisions?
14 April 2021
…resource allocation decisions. WTP thresholds are most immediately relevant in health care systems such as the U.S. where the impact of an increase in expenditure from a new technology is…
The Dynamics of Drug Shortages
9 January 2024
…include higher out-of-pocket payments for patients as well as more resources being diverted to controlling shortages rather than other healthcare resource utilisation. Recommendations Governments around the world have been working…